Key result
Implantable cardioverter-defibrillators are the most effective treatment for patients with life-threatening ventricular tachycardia or fibrillation not due to reversible causes.
The review summarizes ACC/AHA class I and IIa indications for ICDs and highlights the importance of biventricular pacing and optimal medical therapy in this population.
Answers are grounded in this paper and cite their sources.
Supports guideline-directed ICD use for secondary prevention; leaves open optimization of selection and programming with modern adjunctive therapies.
The implantable cardioverter-defibrillator (ICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation not due to reversible causes. The American College of Cardiology/American Heart Association class I and IIa indications for an ICD are discussed. Patients with ICDs who need pacing should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing, at a rate of 70/min. Patients with ICDs should be treated with β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
No takes yet. Share an insight, caveat, or question.
Wilbert S. Aronow (2010) conducted a review in Life-threatening ventricular tachycardia or ventricular fibrillation not due to reversible causes. Implantable cardioverter-defibrillator (ICD) was evaluated. Implantable cardioverter-defibrillators are the most effective treatment for patients with life-threatening ventricular tachycardia or fibrillation not due to reversible causes.
Synapse has enriched 10 related papers. Consider them for comparative context: